Georgia Senate Votes 54 to 1 to Approve Medical Cannabis Bill

marijuana card

Georgia Senate Votes 54 to 1 to Approve Medical Cannabis Bill

Georgia’s MarijuanaSenate has voted 54 to 1 to approve a bill that would allow for the use of cannabis extracts in the treatment of epilepsy. The bill is a far more restrictive version of a measure approved by Georgia’s House of Representatives last month with an 158 to 2 vote.

The sole no vote on the Senate bill, Senator Curth Thomson, calls the measure “virtually worthless” as it only allows for the possession and use of low-THC cannabis oil, and doesn’t authorize anyone but those with epilepsy to consume the medicine. Thompson has recently filed both a broader medical cannabis bill, and a bill to legalize cannabis for recreational use.

The bill approved by Georgia’s House would also only allow cannabis oil to be used medically, and not the whole plant, though those with additional conditions – such as cancer and multiple sclerosis – would be able to become qualified patients, authorized to possess and use cannabis medicine.

The House bill has been sent to the Senate, and the Senate bill has been sent to the House. Lawmakers will need to reconcile the differences before a proposal is sent to Governor Nathan Deal for consideration.

Delta Extrax




  • Anonymous
    March 14, 2015

    Georgia is full of retard politicians! Legalize like alcohol. It can’t hurt no more than alcohol. I don’t know who is more dumber. The politicians or the public who voted for those politicians. They need you let the voters be the judge.

  • scott
    March 15, 2015

    looks like 2 congressmen and 1 senator needs to be replaced for voting NO…..

  • scott
    March 15, 2015

    Dr. Donald Tashkin, Medical Director of the Pulmonary Function Lab at UCLA Medical Center is the world’s leading authority on the respiratory effects of smoking pot.

    His early research discovered the carcinogens in pot smoke and bronchial tissue changes that everyone refers to in claiming lung cancer and respiratory disease from pot smoking.

    His entire career has been devoted to the study of the pulmonary effects of tobacco and cannabis.

    He and his associated research teams from well known universities and labs including Harvard and the Albert Einstein College of Medicine and others are responsible for the majority of research in this field.

    His early research was the basis for the gov’t.’s claim of a link to lung cancer and respiratory disease and the impetus for millions awarded to Tashkin for further research.

    However, after 30 years and millions of dollars of NIDA funded research with a mandated bias in finding the negatives of pot smoking and drug abuse and not the medical benefits of drugs he states unequivocally that he “has been unable to find any positive association at all with increased rates of lung cancer, emphysema or COPD in even the heaviest long term chronic smokers.”


    In fact their rates were lower than both tobacco smokers and non-smokers.

    They also had lower rates of head, neck and throat cancer.

    “We hypothesized that there would be a positive association between marijuana use and lung cancer, and that the association would be more positive with heavier use.”

    “What we found instead was no association at all, and even a suggestion of some protective effect.”

    The largest retrospective meta analysis study of 64,000 patients conducted by Kaiser Permanente reported the same results.

    There are other studies corroborating this as well that can be found easily with a simple internet search.

    Anyone can access and read Dr. Tashkin’s original research papers online and/or hear Dr. Tashkin himself describe the studies in detail in an hour long two part online video interview.

    I’m shocked and puzzled that the journalist and her editor would be unaware of this.

Post a Comment